SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is seeing heightened investor anxiety as community members debate whether the stock's reliance on share dilution and leveraged bitcoin holdings makes it a vulnerable "ponzi" scheme or a long-term accumulation opportunity. Discussions are heavily focused on the stock's proximity to support levels, concerns over the sustainability of dividend obligations, and the potential impact of broader crypto market volatility on the company's treasury strategy.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF is experiencing intense volatility and heavy sentiment polarization, with traders debating whether the sector is in a sustainable super-cycle fueled by massive AI data center demand or a classic speculative bubble nearing a blowoff top. Investors are actively watching for potential catalysts like FOMC decisions and sector-specific earnings, while balancing concerns over leverage, regulatory noise, and the broader macro environment against aggressive dip-buying patterns.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing significant momentum and heightened social media activity driven by reports of a manufacturing partnership with Apple for domestic chip production. The community remains deeply divided, with some investors focusing on the stock's long-term potential as a cornerstone of U.S. semiconductor infrastructure, while others express skepticism over the sustainability of the price action and the reliability of the news flow.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing a strong rally driven by institutional interest and optimism surrounding the upcoming FDA review of compounded weight-loss peptides. While the community is actively debating the stock's path toward previous highs and the potential for a short squeeze, many are focused on the company's expanding telehealth platform and its ability to capture market share in the growing GLP-1 and wellness space.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to the company's recent repurchase of $16 million in convertible notes and the upcoming EMA decision on Yartemlea. While the community is actively debating the strategic implications of debt reduction and potential buyout interest, sentiment remains split between long-term optimism over pipeline catalysts and frustration regarding management's communication style.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense trading volume and volatility as retail investors and algorithms debate whether the memory stock is in a sustainable growth phase or a speculative bubble driven by AI infrastructure demand. The community is heavily split, with bulls pointing to supply shortages and institutional momentum, while bears argue the valuation has decoupled from fundamentals and caution that the stock is poised for a significant correction.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is rallying significantly as investors respond to record revenue, positive cash flow, and an expanding ecosystem of high-profile AI and platform partnerships like Midjourney. The community is actively debating the company's path to long-term profitability while monitoring a heavy short interest that continues to fuel intense speculative trading and price volatility.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors react to a mix of positive clinical updates, including robust 5-year data for its personalized cancer vaccine, and heightened global health concerns surrounding emerging virus outbreaks. Community discussion remains polarized, with some traders actively seeking to capitalize on volatility and potential short-squeeze setups while others remain skeptical about the firm's long-term commercial pivot away from legacy pandemic products.

Arqit Quantum, Inc. engages in the provision of cybersecurity services via satellite and terrestrial forms. Its product is QuantumCloud which secures devices with cloud-based quantum encryption. The company was founded by David John Williams and David James Bestwick on April 26, 2021 and is headquartered in London, the United Kingdom.

Arqit Quantum Inc

Arqit Quantum is experiencing high volatility as investors track significant insider accumulation and a tightening share float, with the community actively speculating on potential government contract catalysts and a possible short squeeze. Sentiment is largely divided between bullish investors eyeing the stock's role in the quantum security sector and skeptics concerned about the company's limited revenue and ongoing legal overhangs.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid intense debate over its role in global financial infrastructure, with the community polarized between those betting on institutional adoption through potential regulatory clarity and those frustrated by stagnant price action and persistent selling pressure. Discussions are heavily focused on the impact of legislative developments like the Clarity Act and the long-term utility of Ripple's payment technology, as investors weigh the potential for a structural rally against ongoing market volatility and skepticism regarding dilution concerns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday

Vivani Medical (NASDAQ:VANI) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Purchases 1,587,301 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,587,301 shares of the company's stock in a transaction that occurred on Wednesday, April 15th. The stock was...

Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,587,301 Shares

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,587,301 shares of the firm's stock in a transaction on Wednesday, April 15th. The shares were purchased at an...

Vivani Medical, Inc. (NASDAQ:VANI) Sees Large Increase in Short Interest

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) saw a significant growth in short interest in March. As of March 31st, there was short interest totaling 532,131 shares, a growth of 65.0% from the March 15th total of 322,575 shares. Currently, 1.2% of the company's stock are sold short. Based...

Vivani Medical (VANI) Upgraded to Buy: What Does It Mean for the Stock?

Vivani Medical (VANI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

HC Wainwright Lifts Earnings Estimates for Vivani Medical

Vivani Medical, Inc. (NASDAQ:VANI - Free Report) - Stock analysts at HC Wainwright increased their Q1 2026 EPS estimates for Vivani Medical in a research note issued to investors on Tuesday, March 31st. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.08) per sh...

HC Wainwright Cuts Vivani Medical (NASDAQ:VANI) Price Target to $3.50

HC Wainwright reduced their price objective on Vivani Medical from $4.00 to $3.50 and set a "buy" rating for the company in a research report on Tuesday...

Vivani Medical (NASDAQ:VANI) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Vivani Medical (NASDAQ:VANI - Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.01...

Vivani Medical (VANI) Projected to Post Quarterly Earnings on Monday

Vivani Medical (NASDAQ:VANI) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at...

Vivani Medical (NASDAQ:VANI) Director Buys $1,685,497.17 in Stock

Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 1,575,231 shares of Vivani Medical stock in a transaction that occurred on Sunday, March 15th. The shares were...

This account has been verified as an official VANI representative.

Verified Account

Vivani Medical

Vivani Medical, Inc. is a preclinical stage biopharmaceutical company, which engages in the business of developing miniaturized, subdermal implants utilizing proprietary NanoPortal technology to enable long-term, near constant-rate delivery of a broad range of medicines to treat chronic diseases. It operates under the Biopharm Division and Neuromodulation Division segments. The company was founded by Adam Mendelsohn on May 22, 2003 and is headquartered in Alameda, CA.

Vivani Medical Inc

Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment Soars

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

VANIVivani Medical Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VANI News